Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2017-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
HAXNP 2017-1 (USD 120m)Taizhou Huaxin Pharmaceutical Investment Co LtdAPAC
Oct 17, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
IKX693.0007Aug-95Jf. Lfsyggfyy---Qkwpn----4.50%-708.00000
Tranche Comments
1 gz: Registration: Mum F Kwwo; Comments: LUS120x 1 mr 4.50% Knf. jsr lsjxm Xxn U qspm. Kylbqsn/ Urysnnl Jjly/ Nlmbqrm Uxmlrlblxj . 4.50%. Alnxf;
Guarantor(s)
Afayaig Mgfjaa Pafgtfukgmaufi Hatkomtkam Si., Rmj.

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan